Old Web
English
Sign In
Acemap
>
authorDetail
>
Jessie Hou
Jessie Hou
Beckman Research Institute
Immunology
CD30
Molecular biology
Brentuximab vedotin
Monomethyl auristatin E
3
Papers
38
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine, administered with tetrahydrouridine
2015
Cancer Chemotherapy and Pharmacology
Edward M. Newman
Robert Morgan
Shivaani Kummar
Jan H. Beumer
M. Suzette Blanchard
Christopher Ruel
Anthony B. El-Khoueiry
Mary I. Carroll
Jessie Hou
Chun Li
Heinz J. Lenz
Julie L. Eiseman
James H. Doroshow
Show All
Source
Cite
Save
Citations (36)
Downregulation of CD30, Resistance to MMAE, and Upregulation of MDR1 Are All Associated with Resistance to Brentuximab Vedotin
2014
Blood
Robert Chen
Jessie Hou
Edward M. Newman
Young Kim
Cecile Donohue
Stephen J. Forman
Susan E. Kane
Show All
Source
Cite
Save
Citations (1)
Selection For Brentuximab Vedotin Resistant Lymphoma Cell Lines Leads To Downregulation Of Surface CD30 Expression
2013
Blood
Robert Chen
Jessie Hou
Megan Reddy
Edward M. Newman
Stephen J. Forman
Susan E. Kane
Show All
Source
Cite
Save
Citations (1)
1